8 completed, 2 terminated, 2 unknown, 1 active not recruiting. 5 Not applicable, 4 Phase 2, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 3, Terminated 1, Unknown 1 |
| Phase 2 | 4 | Completed 3, Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Verruca Vulgaris: new trials by email Literature Review of Verruca Vulgaris trials Research Report on Verruca Vulgaris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts 9-valent human papillomavirus vaccine, Sterile Saline - Warts, Verruca (Warts) | Phase 2 | Active not recruiting | Rush University Medical Center | 55 | 2025-09-02 | 2026-09-15 |
| Cold Atmospheric Plasma Device Extension Study Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP) - Verruca Vulgaris, Molluscum Contagiosum | Phase 3 | Terminated | Medical University of South Carolina | 60 | 2023-09-18 | 2026-04-03 |
| Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts VDMN-21 Patch Low Dose, VDMN-21 Patch High Dose, Vehicle Patch - Verruca Vulgaris, Warts | Phase 2 | Completed | Veradermics, Inc. | 153 | 2023-02-28 | 2025-05-08 |
| Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris Immunohistochemical staining monoclonal antibodies to SCCA2 (SERPINB4/ SCCA2 antibody) - Verruca Vulgaris, Healthy | Unknown | Sohag University | 50 | 2022-05-01 | 2022-06-10 | |
| Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP), Cryotherapy, Canthardin Collodion - Verruca Vulgaris, Molluscum Contagiosum Skin Infection | Phase 4 | Completed | Medical University of South Carolina | 17 | 2021-12-02 | 2024-04-05 |
| Photodynamic Therapy in Treatment of Verrucae methylene blue / IPL, IPL, saline - Verruca Vulgaris | Not applicable | Unknown | Alexandria University | 80 | 2020-01-01 | 2021-07-26 |
| Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study Cholecalciferol - Verruca Vulgaris, Involucrin | Not applicable | Completed | Benha University | 60 | 2019-01-01 | 2023-07-27 |
| Cantharidin and Occlusion in Verruca Epithelium VP-102 Cantharidin topical film forming solution, VP-102 Cantharidin, topical film forming solution - Common Wart, Warts Hand | Phase 2 | Completed | Verrica Pharmaceuticals Inc. | 56 | 2018-03-27 | 2024-11-27 |
| Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. ingenol mebutate 0.05% gel - Verruca Vulgaris, Common Warts | Phase 1 | Completed | Neal D. Bhatia, MD | 16 | 2016-04-27 | 2017-07-17 |
| ALC-919 For The Treatment Of Common Warts 2014-ALC-919-US, Vehicle-Control Topical Solution - Verruca Vulgaris | Phase 2 | Completed | Veloce BioPharma LLC | 21 | 2015-04-01 | 2016-03-09 |
| Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy Liquid Nitrogen Cryotherapy, Pulsed 1064nm Nd:YAG - Verruca Vulgaris | Not applicable | Terminated | Trinity Health Michigan | 31 | 2012-01-01 | 2018-03-22 |
| A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin Liquid nitrogen and cantharidin, Liquid nitrogen and topical placebo - Verruca Vulgaris | Not applicable | Completed | North Idaho Dermatology | 70 | 2007-06-01 | 2010-03-11 |
| Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts duct tape occlusion therapy - Wart, Common Wart | Not applicable | Completed | Minneapolis Veterans Affairs Medical Center | 90 | 2004-10-01 | 2006-05-24 |
Warts (13) · DNA Virus Infections (1) · Molluscum Contagiosum (1) · Papillomavirus Infections (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Skin Diseases, Viral (1) · Tumor Virus Infections (1) · Virus Diseases (1)
Infections (13) · Skin and Connective Tissue Diseases (13) · DNA Virus Infections (12) · Papillomavirus Infections (12) · Skin Diseases (12) · Skin Diseases, Infectious (12) · Skin Diseases, Viral (12) · Tumor Virus Infections (12) · Virus Diseases (12) · Communicable Diseases (1) · Disease Attributes (1) · Genital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Poxviridae Infections (1)
Cantharidin (2) · Cryotherapy (2) · 3-ingenyl angelate (1) · Cholecalciferol (1) · Gels (1) · Heart Rate (1) · Lasers (1) · Methylene Blue (1) · Sodium Chloride (1) · leupin (1)
Medical University of South Carolina (2) · Alexandria University (1) · Benha University (1) · Minneapolis Veterans Affairs Medical Center (1) · Neal D. Bhatia, MD (1) · North Idaho Dermatology (1) · Rush University Medical Center (1) · Sohag University (1) · Trinity Health Michigan (1) · Veloce BioPharma LLC (1) · Veradermics, Inc. (1) · Verrica Pharmaceuticals Inc. (1)
United States (10) · Egypt (3)
Adnan Nasir, MD (1) · Andrew Pollack, MD (1) · Barry Auster, MD (1) · Erin M. Warshaw, MD (1) · Lara Wine Lee, MD, PhD (1) · Neal D Bhatia, MD (1) · Richard A Flygare, PhD (1) · Scott Guenthner, MD (1)